FILTER

FILTERED INTERVIEW RESULTS

Mining
Peru
Chile
Ecuador

Wilson Miranda

GENERAL MANAGER, CONFIPETROL ANDINA
Confipetrol is extending the services that it offers to mining clients in Peru to Chile and Ecuador.
Mining
Peru

Oscar Gonzalez Rocha

PRESIDENT & CEO, SOUTHERN COPPER
Southern Copper outlines its handling of the pandemic and its ambitions in Peru.
Mining
Peru

Ignacio Bustamante

PRESIDENT & CEO, HOCHSCHILD MINING
Hochschild Mining has a busy last quarter ahead with ambitious drilling programs for its mines in Peru and the America’s more generally.
Mining
Peru

Gonzalo Díaz Pró

GENERAL MANAGER, FERREYROS S.A.
Ferreyros represents CAT machinery in Peru and comments on current business conditions.
Peru
Mexico
Petrochemicals & Chemicals
United States
Colombia
Ecuador

Peter Staartjes

CEO, ANDINO HOLDINGS
Andino Holdings comments on the factors influencing the chemical distribution market in Latin America for 2020.
Mining
Peru

Gianflavio Carozzi

CEO, AESA
ASEA speaks of the importance of training to ensure safe and efficient operations.
Mining
Peru
Canada
Namibia
Burkina Faso
MACIG

Ricus Grimbeek

PRESIDENT AND CEO, TREVALI
Trevali Mining examines the challenges of mining in the time of COVID-19 and how efforts to reduce costs have been rewarded.
Mining
Peru

Eduardo Cossio Chirinos

CEO, INCIMMET
INCIMMET is exporting its services to the mining industry from Peru throughout Latin America.
Mining
Peru

Dr. Graham Carman

CEO, TINKA RESOURCES
Tinka Resources explains the recent developments at its Ayawilca zinc project in Peru.
Mining
Peru

Alejandro Caicedo

GENERAL MANAGER PERU, ORICA
Orica in Peru explains how it intends to become the country’s leading provider for blasting and how it is developing and applying technology to improve the process.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL